James Paul Rickey, See Remarks at ALPINE IMMUNE SCIENCES, INC. (ALPN), sold 191,764 shares at $25.00 ($4.4M) on 2024-01-26, disclosed to the SEC on 2024-01-29.
Scheduled sale ($4.4M) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.00 | 236 | $5K | 0.1% |
| 2 | $22.31 | 73,764 | $1.6M | 37.4% |
| 3 | $22.31 | 73,764 | $1.6M | 37.4% |
| 4 | $25.00 | 44,000 | $1.1M | 25.0% |
| Total | $22.93 avg | 191,764 | $4.4M | 100% |
| Filing → |
| ALPN | SELL | 2023-12-18 | $2.0M | — | Filing → |
| ALPN | SELL | 2023-12-06 | $2.3M | — | Filing → |
| ALPN | SELL | 2023-12-01 | $11K | — | Filing → |